Developer docs
API playgroundTry for free, no card

Search company profiles

Roquette America

Full company profile

uuid00049bl

Namestring
Roquette America
Legal namestring
Roquette Frères
Websiteurl
roquette.com
Company typeenum
Private
Founded yearint
1933
Descriptiontext

Roquette America is the US subsidiary of Roquette Frères, a French family-owned global leader in plant-based ingredients founded in 1933 and headquartered in Lestrem, France. The company operates a proprietary biorefinery model that processes over 6 million tons annually of renewable agricultural raw materials (corn, wheat, potato, pea, fava bean, seaweed, cellulose) into more than 700 ingredients, including plant proteins (NUTRALYS), soluble fibers (NUTRIOSE), specialty starches (CLEARAM), polyols (SWEETPEARL), maltodextrins (GLUCIDEX), pharmaceutical excipients, and bio-based chemicals (BIOSUCCINIUM). It serves 5,000+ customers across six segments — Food & Nutrition, Health & Pharma, Cosmetics, Animal Nutrition, Bioindustry, and Agriscience — through 40+ manufacturing sites and 20+ R&D centers in 150+ countries.

The business model is enterprise B2B with direct sales, quote-based pricing, and deep Customer Technical Services (CTS) integration. Approximately 1 in 2 oral dosage forms globally contain Roquette excipients and 45 billion modified-release tablets annually include its products, illustrating deep embedded positioning in regulated pharma supply chains. The FY2025 acquisition of IFF Pharma Solutions for up to $2.85 billion — financed in part by an inaugural €1.2 billion bond — transformed Roquette into a top-tier pharmaceutical excipients and consumer healthcare supplier, adding capsule technologies (Qualicaps, SeaGel, LYCAGEL Flex, VERDIGEL) and drug delivery systems. FY2025 consolidated turnover was €4.9 billion with EBITDA of €612 million (12.6% margin), supported by 11,000+ employees worldwide. The company remains family-controlled under Chairman Edouard Roquette, with Thierry Fournier as CEO, and operates without external private equity or venture capital backing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersGurnee, United States
HQ citystring
Gurnee
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices17 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plant-based ingredients, pharmaceutical excipients, pea protein isolates, specialty starches, biorefinery materials
Industry2 codes
PRIMARYAFAHAJAI
Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B)
Agriculture & Food Production/Dairy Processing/Dairy Alternatives Processing (Plant-Based “Milk”, Yogurt & Cheese Analogues)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
NAICS code3 codes
  • Starch and Vegetable Fats and Oils Manufacturing31122
  • Food Manufacturing311
  • Grain and Oilseed Milling3112
SIC code3 codes
  • Food And Kindred Products2000
  • Grain Mill Products2040
  • Industrial Organic Chemicals2860
Product category
Plant-based ingredients for food and pharmaceutical applications
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Plant-Based Ingredients B2B Sales
TypeOne Time License
Description

Roquette generates revenue through direct B2B sales of plant-based ingredients and pharmaceutical excipients to food manufacturers, pharmaceutical companies, cosmetics brands, and industrial customers worldwide. Revenue stream includes proteins, fibers, starches, polyols, maltodextrins, and specialty ingredients sold under brand names including NUTRALYS, NUTRIOSE, CLEARAM, METHOCEL, SWEETPEARL, and GLUCIDEX.

roquette.com
2Pharmaceutical Excipients and Solutions
TypeOne Time License
Description

Revenue from pharmaceutical excipients, capsules, and drug delivery solutions. Includes hard capsules (Qualicaps), coating systems, and functional excipients for oral dosage, biologics, and consumer healthcare products. Expanded significantly through 2025 acquisition of IFF Pharma Solutions.

globenewswire.com
3Specialty Ingredients
TypeOne Time License
Description

Specialty ingredients for bioindustry applications including fermentation carbon sources, BIOSUCCINIUM bio-succinic acid, POLYSORB isosorbide, alginates, and cellulosics for industrial customers in paper, packaging, construction, home care, and biofuel sectors.

roquette.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1Roquette Beauté
Description

Cosmetics ingredient brand delivering high-performance, sustainable ingredients for cosmetic products

roquette.com
+10 more records
Core offering1 text field

Roquette America manufactures and sells plant-based ingredients for food, pharmaceutical, cosmetic, and industrial applications, processing renewable agricultural raw materials (corn, wheat, potato, pea) through a proprietary biorefinery model. The company produces over 700 ingredients including plant proteins, fibers, starches, polyols, maltodextrins, pharmaceutical excipients, capsules, and bio-based chemicals sold under brands such as NUTRALYS, NUTRIOSE, CLEARAM, SWEETPEARL, GLUCIDEX, METHOCEL, and BIOSUCCINIUM.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • ~1 out of 2 oral dosage forms contain two or more Roquette excipients
+5 more records
Product overview1 text field

Roquette America offers a comprehensive portfolio of plant-based ingredients and pharmaceutical solutions across multiple business units. The core Food & Nutrition segment includes NUTRALYS® plant proteins (pea and fava protein isolates and textured proteins), NUTRIOSE® soluble fibers, CLEARAM® specialty starches, METHOCEL™ cellulosics, SWEETPEARL® polyols, and GLUCIDEX® maltodextrins. The Health & Pharma Solutions segment provides pharmaceutical excipients, capsules (through Qualicaps), and advanced drug delivery systems. Consumer Healthcare offerings include SeaGel® carrageenan softgels, LYCAGEL® Flex, and VERDIGEL™ pectin solutions. The Bioindustry segment features BIOSUCCINIUM® bio-succinic acid, POLYSORB® isosorbide, SOLULYS® fermentation proteins, and alginate products. Roquette Beauté serves the cosmetics market with alginate-based ingredients and innovative capsule technologies like DS 700. The portfolio also includes the HORIZONS AI-powered foresight platform. Recent strategic acquisitions including IFF Pharma Solutions and Qualicaps have expanded capabilities in pharmaceutical excipients and capsule technologies.

Product and service21 records
1NUTRALYS Plant Proteins
CategoryPlant-based proteins
Description

Pea and fava bean protein isolates and textured proteins for food and nutrition applications including plant-based meat alternatives, dairy alternatives, sports nutrition, and beverages.

2NUTRIOSE Soluble Fibers
CategorySoluble fibers
Description

Soluble fiber ingredients for fiber enrichment in food and beverage applications, supporting gut health and digestive wellness.

3CLEARAM and Specialty Starches
CategorySpecialty starches
Description

Starch-based ingredients including tapioca, corn, and other botanical starches for texturizing, thickening, and binding in food applications.

4METHOCEL and Cellulosics
CategoryCellulosics
Description

Cellulose derivatives and methylcellulose products for texturizing, film-forming, and functional properties in food, pharmaceutical, and industrial applications.

5SWEETPEARL and Polyols
CategoryPolyols / sugar alcohols
Description

Sugar alcohols including sorbitol, maltitol, and xylitol for sugar reduction, confectionery, and oral care applications.

6GLUCIDEX Maltodextrins
CategoryMaltodextrins
Description

Maltodextrins and dried glucose syrup as carbohydrates for food processing, fermentation carbon sources, and functional ingredients.

7Pharmaceutical Excipients
CategoryPharmaceutical excipients
Description

Functional excipients for oral dosage forms including binding agents, disintegrants, fillers, and coating systems for pharmaceutical formulations. Portfolio expanded through IFF Pharma Solutions acquisition.

8Qualicaps Capsules
CategoryHard capsules
Description

Hard capsule technologies including HPMC and gelatin capsules for pharmaceutical and nutraceutical applications, acquired through 2023 Qualicaps acquisition.

9Biologics Excipients
CategoryBiologics excipients
Description

Functional excipients supporting protein stabilization, viscosity reduction, and bioprocessing efficiency in biologic drug development.

10Advanced Drug Delivery Systems
CategoryDrug delivery systems
Description

Controlled and targeted release technologies with multifunctional excipients and advanced formulation solutions for enhanced bioavailability and patient compliance.

11Coating Systems
12BIOSUCCINIUM Bio-succinic Acid
CategoryBio-based chemicals
Description

Plant-based succinic acid for improving environmental footprint in packaging, coatings, and high-quality chemical intermediates for biobased materials.

13POLYSORB Isosorbide
CategoryBio-based monomers
Description

Versatile monomer optimizing heat and surface resistance, optical properties, recyclability, carbon footprint, and polymer safety for performance materials.

14STABILYS BA 25
CategoryIndustrial starches
Description

Modified starch designed to deliver high-performance grease resistance for paper and board packaging, enabling removal of fluoropolymers.

15SeaGel Softgel Technology
CategorySoftgel capsules
Description

Carrageenan-based softgel technology for dietary supplements and OTC products, providing consumer-friendly delivery solutions.

16LYCAGEL Flex Softgel Technology
CategorySoftgel capsules
Description

Softgel technology for consumer healthcare and nutraceutical applications, expanded through recent acquisitions.

17VERDIGEL Pectin Solutions
CategoryPectin solutions
Description

Pectin-based solutions for gummy formulations in dietary supplements and OTC products, supporting clean-label and plant-based positioning.

18Beauté by Roquette AG Series
CategoryCosmetic ingredients
Description

Alginate-based technologies for cosmetics including AG 215, AG 219, and AG 291, offering enhanced rheology and viscosity for skin care, hair care, and color cosmetics.

19Beauté by Roquette DS 700
CategoryCosmetic ingredients
Description

Water-resistant capsule with nearly 100% resistance designed for long-lasting beauty applications in personal care.

20QUALIS-Pro UV Laser Tablet Printing System
CategoryPharmaceutical manufacturing equipment
Description

Next-generation UV laser tablet printing and inspection system integrating advanced printing and inspection technology for pharmaceutical manufacturing.

21AMYSTA L 123 Thermally Soluble Pea Starch
CategoryLabel-friendly starches
Description

Label-friendly thermally soluble pea starch designed as a label-friendly solution for food manufacturers.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Multi-year supply agreement for pea protein covering 2026 and 2027 to secure Beyond Meat's supply chain amid challenging plant-based market conditions. Roquette supplies Nutralys pea protein isolates for plant-based meat alternative products.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-01
Description

Strategic collaboration to enhance production of tagatose, a natural sweetener with health benefits. Partnership focuses on technological and scale-up development to meet growing demand for healthier sugar alternatives in food formulations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-01
Description

Roquette acquired IFF Pharma Solutions business for up to $2.85 billion in 2025, strengthening pharmaceutical offerings. The acquisition included excipients for oral dosage solutions and expanded Roquette's capsule portfolio through Qualicaps acquisition.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Industry collaboration through annual conference to advance plant-based protein sector in Canada, discussing supply chain sustainability, grower relationships, and market challenges.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Key competitor in plant-based protein market. Both companies investing in alternative protein technologies and capacity expansion.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership between LDC and Seven Oaks Hospital to develop new pea protein ingredients focusing on health benefits for older adults. LDC opened $500 million pea protein isolate plant in Canada in February 2024.

Recent move16 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Ingredion is a leading global ingredient solutions provider specializing in starches, sweeteners, and plant-based proteins derived from corn, tapioca, and other crops. Direct competitor to Roquette across food ingredients, polyols, and specialty starches with comparable B2B enterprise sales model.

TypeDirect peer
Description

ADM is a global leader in plant-based proteins, particularly pea and soy protein isolates used in meat alternatives, with significant investment in alternative protein capacity. Direct competitor to Roquette in food, plant-based nutrition, and bioindustry ingredients.

TypeDirect peer
Description

Tate & Lyle is a specialty food ingredients company focused on sweeteners, texturants, and fibers including soluble corn fiber and polyols. Direct competitor to Roquette in food ingredients, sugar reduction, and specialty starch applications.

TypeBroad incumbent
Description

Cargill is one of the world's largest agricultural commodity processors with extensive plant-based protein, starch, and bioindustrial ingredient operations. Broad incumbent across food, animal nutrition, and bioindustry with overlapping capabilities to Roquette but operating at much larger and more diversified scale.

TypeDirect peer
Description

Kerry Group is a global B2B ingredient supplier focused on taste and nutrition systems, including plant-based proteins, fibers, and functional ingredients for food manufacturers. Direct competitor to Roquette in food and nutrition, with comparable customer base among food and beverage manufacturers.

TypeDirect peer
Description

DSM-Firmenich is a global nutrition, health, and beauty ingredients company with overlapping capabilities in plant-based proteins, vitamins, and pharmaceutical excipients. Direct competitor in nutrition, personal care, and pharma excipients with comparable R&D and B2B go-to-market model.

TypeDirect peer
Description

Glanbia is a global nutrition company specializing in dairy and plant-based protein ingredients, including pea protein for food and beverage applications. Direct competitor in plant-based protein and nutrition markets with comparable ingredient portfolio to Roquette's NUTRALYS line.

TypeDirect peer
Description

Corbion is a Dutch biobased ingredients company producing lactic acid, alginates, and biobased chemicals from renewable feedstocks. Direct peer in bioindustry and bio-based chemicals with comparable renewable-feedstock biorefinery model to Roquette's BIOSUCCINIUM and POLYSORB products.

TypeRegional player
Description

Südzucker is Europe's largest sugar producer with a substantial starch/fruit ingredients division (Agrana) producing starches, polyols, and bioethanol from corn, wheat, and potato. Direct peer in starch and polyol manufacturing with strong European regional overlap to Roquette's core markets.

TypeDirect peer
Description

Lonza is a global contract manufacturing and ingredients company serving pharmaceutical, nutrition, and personal care customers, with significant excipient and cellulosics production. Direct competitor in pharmaceutical excipients following Roquette's acquisition of IFF Pharma Solutions, with comparable pharma CDMO-adjacent capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance16 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Roquette America

Plant-based ingredients for food and pharmaceutical applicationsroquette.com

What Roquette America does

Roquette America is the US subsidiary of Roquette Frères, a French family-owned global leader in plant-based ingredients founded in 1933 and headquartered in Lestrem, France. The company operates a proprietary biorefinery model that processes over 6 million tons annually of renewable agricultural raw materials (corn, wheat, potato, pea, fava bean, seaweed, cellulose) into more than 700 ingredients, including plant proteins (NUTRALYS), soluble fibers (NUTRIOSE), specialty starches (CLEARAM), polyols (SWEETPEARL), maltodextrins (GLUCIDEX), pharmaceutical excipients, and bio-based chemicals (BIOSUCCINIUM). It serves 5,000+ customers across six segments — Food & Nutrition, Health & Pharma, Cosmetics, Animal Nutrition, Bioindustry, and Agriscience — through 40+ manufacturing sites and 20+ R&D centers in 150+ countries.

The business model is enterprise B2B with direct sales, quote-based pricing, and deep Customer Technical Services (CTS) integration. Approximately 1 in 2 oral dosage forms globally contain Roquette excipients and 45 billion modified-release tablets annually include its products, illustrating deep embedded positioning in regulated pharma supply chains. The FY2025 acquisition of IFF Pharma Solutions for up to $2.85 billion — financed in part by an inaugural €1.2 billion bond — transformed Roquette into a top-tier pharmaceutical excipients and consumer healthcare supplier, adding capsule technologies (Qualicaps, SeaGel, LYCAGEL Flex, VERDIGEL) and drug delivery systems. FY2025 consolidated turnover was €4.9 billion with EBITDA of €612 million (12.6% margin), supported by 11,000+ employees worldwide. The company remains family-controlled under Chairman Edouard Roquette, with Thierry Fournier as CEO, and operates without external private equity or venture capital backing.

Roquette America firmographics

Firmographics
Name
Roquette America
Legal name
Roquette Frères
Website
https://roquette.com
Company type
Private
Founded year
1933
Operating status
Operating
Headcount range
10,001+ employees
Ownership category
akta.pro rank

Roquette America industry classification

Industry
Product category
Plant-based ingredients for food and pharmaceutical applications
NAICS
Starch and Vegetable Fats and Oils Manufacturing (31122), Food Manufacturing (311), Grain and Oilseed Milling (3112)
SIC
Food And Kindred Products (2000), Grain Mill Products (2040), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYAFAHAJAI
Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B)
Agriculture & Food Production/Dairy Processing/Dairy Alternatives Processing (Plant-Based “Milk”, Yogurt & Cheese Analogues)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)

Keywords

  • Plant-based ingredients
  • Pharmaceutical excipients
  • Pea protein isolates
  • Specialty starches
  • Biorefinery materials

Where Roquette America is headquartered

Location

Headquarters

HQ city
Gurnee
HQ country
United States
HQ region
North America

Offices17 records

Markets served

Roquette America business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Plant-Based Ingredients B2B Sales: Roquette generates revenue through direct B2B sales of plant-based ingredients and pharmaceutical excipients to food manufacturers, pharmaceutical companies, cosmetics brands, and industrial customers worldwide. Revenue stream includes proteins, fibers, starches, polyols, maltodextrins, and specialty ingredients sold under brand names including NUTRALYS, NUTRIOSE, CLEARAM, METHOCEL, SWEETPEARL, and GLUCIDEX.
  2. Pharmaceutical Excipients and Solutions: Revenue from pharmaceutical excipients, capsules, and drug delivery solutions. Includes hard capsules (Qualicaps), coating systems, and functional excipients for oral dosage, biologics, and consumer healthcare products. Expanded significantly through 2025 acquisition of IFF Pharma Solutions.
  3. Specialty Ingredients: Specialty ingredients for bioindustry applications including fermentation carbon sources, BIOSUCCINIUM bio-succinic acid, POLYSORB isosorbide, alginates, and cellulosics for industrial customers in paper, packaging, construction, home care, and biofuel sectors.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Roquette America product offering

Product offering

Core offering

Roquette America manufactures and sells plant-based ingredients for food, pharmaceutical, cosmetic, and industrial applications, processing renewable agricultural raw materials (corn, wheat, potato, pea) through a proprietary biorefinery model. The company produces over 700 ingredients including plant proteins, fibers, starches, polyols, maltodextrins, pharmaceutical excipients, capsules, and bio-based chemicals sold under brands such as NUTRALYS, NUTRIOSE, CLEARAM, SWEETPEARL, GLUCIDEX, METHOCEL, and BIOSUCCINIUM.

Product overview

Roquette America offers a comprehensive portfolio of plant-based ingredients and pharmaceutical solutions across multiple business units. The core Food & Nutrition segment includes NUTRALYS® plant proteins (pea and fava protein isolates and textured proteins), NUTRIOSE® soluble fibers, CLEARAM® specialty starches, METHOCEL™ cellulosics, SWEETPEARL® polyols, and GLUCIDEX® maltodextrins. The Health & Pharma Solutions segment provides pharmaceutical excipients, capsules (through Qualicaps), and advanced drug delivery systems. Consumer Healthcare offerings include SeaGel® carrageenan softgels, LYCAGEL® Flex, and VERDIGEL™ pectin solutions. The Bioindustry segment features BIOSUCCINIUM® bio-succinic acid, POLYSORB® isosorbide, SOLULYS® fermentation proteins, and alginate products. Roquette Beauté serves the cosmetics market with alginate-based ingredients and innovative capsule technologies like DS 700. The portfolio also includes the HORIZONS AI-powered foresight platform. Recent strategic acquisitions including IFF Pharma Solutions and Qualicaps have expanded capabilities in pharmaceutical excipients and capsule technologies.

Differentiator

Problem solved

Functional benefit

Brands

  • Roquette Beauté: Cosmetics ingredient brand delivering high-performance, sustainable ingredients for cosmetic products
  • NUTRALYS®
  • NUTRIOSE®
  • CLEARAM®
  • SWEETPEARL®
  • GLUCIDEX®
  • BIOSUCCINIUM®
  • Qualicaps
  • SeaGel®
  • VERDIGEL™
  • AMYSTA™

Products and services

  • NUTRALYS Plant Proteins Pea and fava bean protein isolates and textured proteins for food and nutrition applications including plant-based meat alternatives, dairy alternatives, sports nutrition, and beverages.
  • NUTRIOSE Soluble Fibers Soluble fiber ingredients for fiber enrichment in food and beverage applications, supporting gut health and digestive wellness.
  • CLEARAM and Specialty Starches Starch-based ingredients including tapioca, corn, and other botanical starches for texturizing, thickening, and binding in food applications.
  • METHOCEL and Cellulosics Cellulose derivatives and methylcellulose products for texturizing, film-forming, and functional properties in food, pharmaceutical, and industrial applications.
  • SWEETPEARL and Polyols Sugar alcohols including sorbitol, maltitol, and xylitol for sugar reduction, confectionery, and oral care applications.
  • GLUCIDEX Maltodextrins Maltodextrins and dried glucose syrup as carbohydrates for food processing, fermentation carbon sources, and functional ingredients.
  • Pharmaceutical Excipients Functional excipients for oral dosage forms including binding agents, disintegrants, fillers, and coating systems for pharmaceutical formulations. Portfolio expanded through IFF Pharma Solutions acquisition.
  • Qualicaps Capsules Hard capsule technologies including HPMC and gelatin capsules for pharmaceutical and nutraceutical applications, acquired through 2023 Qualicaps acquisition.
  • Biologics Excipients Functional excipients supporting protein stabilization, viscosity reduction, and bioprocessing efficiency in biologic drug development.
  • Advanced Drug Delivery Systems Controlled and targeted release technologies with multifunctional excipients and advanced formulation solutions for enhanced bioavailability and patient compliance.
  • Coating Systems
  • BIOSUCCINIUM Bio-succinic Acid Plant-based succinic acid for improving environmental footprint in packaging, coatings, and high-quality chemical intermediates for biobased materials.
  • POLYSORB Isosorbide Versatile monomer optimizing heat and surface resistance, optical properties, recyclability, carbon footprint, and polymer safety for performance materials.
  • STABILYS BA 25 Modified starch designed to deliver high-performance grease resistance for paper and board packaging, enabling removal of fluoropolymers.
  • SeaGel Softgel Technology Carrageenan-based softgel technology for dietary supplements and OTC products, providing consumer-friendly delivery solutions.
  • LYCAGEL Flex Softgel Technology Softgel technology for consumer healthcare and nutraceutical applications, expanded through recent acquisitions.
  • VERDIGEL Pectin Solutions Pectin-based solutions for gummy formulations in dietary supplements and OTC products, supporting clean-label and plant-based positioning.
  • Beauté by Roquette AG Series Alginate-based technologies for cosmetics including AG 215, AG 219, and AG 291, offering enhanced rheology and viscosity for skin care, hair care, and color cosmetics.
  • Beauté by Roquette DS 700 Water-resistant capsule with nearly 100% resistance designed for long-lasting beauty applications in personal care.
  • QUALIS-Pro UV Laser Tablet Printing System Next-generation UV laser tablet printing and inspection system integrating advanced printing and inspection technology for pharmaceutical manufacturing.
  • AMYSTA L 123 Thermally Soluble Pea Starch Label-friendly thermally soluble pea starch designed as a label-friendly solution for food manufacturers.

Quantifiable outcome

  • ~1 out of 2 oral dosage forms contain two or more Roquette excipients
  • +5 more outcomes

Companies that use Roquette America

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles4 records

Roquette America technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Roquette America partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Beyond MeatcoreStrategic or Co-development Partner · 1 January 2026Multi-year supply agreement for pea protein covering 2026 and 2027 to secure Beyond Meat's supply chain amid challenging plant-based market conditions. Roquette supplies Nutralys pea protein isolates for plant-based meat alternative products.
  • BonumosecoreStrategic or Co-development Partner · 1 July 2024Strategic collaboration to enhance production of tagatose, a natural sweetener with health benefits. Partnership focuses on technological and scale-up development to meet growing demand for healthier sugar alternatives in food formulations.
  • IFF (International Flavors & Fragrances)coreStrategic or Co-development Partner · 1 March 2024Roquette acquired IFF Pharma Solutions business for up to $2.85 billion in 2025, strengthening pharmaceutical offerings. The acquisition included excipients for oral dosage solutions and expanded Roquette's capsule portfolio through Qualicaps acquisition.
  • Plant-Based Foods of CanadaminorStrategic or Co-development PartnerIndustry collaboration through annual conference to advance plant-based protein sector in Canada, discussing supply chain sustainability, grower relationships, and market challenges.
  • ADMminorStrategic or Co-development PartnerKey competitor in plant-based protein market. Both companies investing in alternative protein technologies and capacity expansion.
  • Louis Dreyfus Company (LDC)minorStrategic or Co-development PartnerPartnership between LDC and Seven Oaks Hospital to develop new pea protein ingredients focusing on health benefits for older adults. LDC opened $500 million pea protein isolate plant in Canada in February 2024.

Scale indicators13 records

Recent moves16 records

Expansion highlights6 records

Roquette America competitors and assessment

Company assessment

Direct peers

  • Ingredion: Ingredion is a leading global ingredient solutions provider specializing in starches, sweeteners, and plant-based proteins derived from corn, tapioca, and other crops. Direct competitor to Roquette across food ingredients, polyols, and specialty starches with comparable B2B enterprise sales model.
  • ADM (Archer Daniels Midland): ADM is a global leader in plant-based proteins, particularly pea and soy protein isolates used in meat alternatives, with significant investment in alternative protein capacity. Direct competitor to Roquette in food, plant-based nutrition, and bioindustry ingredients.
  • Tate & Lyle: Tate & Lyle is a specialty food ingredients company focused on sweeteners, texturants, and fibers including soluble corn fiber and polyols. Direct competitor to Roquette in food ingredients, sugar reduction, and specialty starch applications.
  • Kerry Group: Kerry Group is a global B2B ingredient supplier focused on taste and nutrition systems, including plant-based proteins, fibers, and functional ingredients for food manufacturers. Direct competitor to Roquette in food and nutrition, with comparable customer base among food and beverage manufacturers.
  • DSM-Firmenich: DSM-Firmenich is a global nutrition, health, and beauty ingredients company with overlapping capabilities in plant-based proteins, vitamins, and pharmaceutical excipients. Direct competitor in nutrition, personal care, and pharma excipients with comparable R&D and B2B go-to-market model.
  • Glanbia: Glanbia is a global nutrition company specializing in dairy and plant-based protein ingredients, including pea protein for food and beverage applications. Direct competitor in plant-based protein and nutrition markets with comparable ingredient portfolio to Roquette's NUTRALYS line.
  • Corbion: Corbion is a Dutch biobased ingredients company producing lactic acid, alginates, and biobased chemicals from renewable feedstocks. Direct peer in bioindustry and bio-based chemicals with comparable renewable-feedstock biorefinery model to Roquette's BIOSUCCINIUM and POLYSORB products.
  • Lonza: Lonza is a global contract manufacturing and ingredients company serving pharmaceutical, nutrition, and personal care customers, with significant excipient and cellulosics production. Direct competitor in pharmaceutical excipients following Roquette's acquisition of IFF Pharma Solutions, with comparable pharma CDMO-adjacent capabilities.

Broad incumbents

  • Cargill: Cargill is one of the world's largest agricultural commodity processors with extensive plant-based protein, starch, and bioindustrial ingredient operations. Broad incumbent across food, animal nutrition, and bioindustry with overlapping capabilities to Roquette but operating at much larger and more diversified scale.

Regional players

  • Südzucker: Südzucker is Europe's largest sugar producer with a substantial starch/fruit ingredients division (Agrana) producing starches, polyols, and bioethanol from corn, wheat, and potato. Direct peer in starch and polyol manufacturing with strong European regional overlap to Roquette's core markets.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Roquette America social profiles

Digital presence

Roquette America compliance and trust

Trust signal

Compliance16 records

Roquette America financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Roquette America leadership team

Management profile

Number of profiles

Profiles12 records

Roquette America subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Roquette America funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Roquette America M&A and investment

M&A and investment

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roquette America

What does Roquette America do?

Roquette America manufactures and sells plant-based ingredients for food, pharmaceutical, cosmetic, and industrial applications, processing renewable agricultural raw materials (corn, wheat, potato, pea) through a proprietary biorefinery model. The company produces over 700 ingredients including plant proteins, fibers, starches, polyols, maltodextrins, pharmaceutical excipients, capsules, and bio-based chemicals sold under brands such as NUTRALYS, NUTRIOSE, CLEARAM, SWEETPEARL, GLUCIDEX, METHOCEL, and BIOSUCCINIUM.

Is Roquette America a public or private company?

Roquette America is a private company. It is classified as family owned and is currently operating.

When was Roquette America founded?

Roquette America was founded in 1933. It employs 10,001+ people.

Where is Roquette America based?

Roquette America is headquartered in Gurnee, United States, in the North America region.

How does Roquette America make money?

Three revenue lines are on record. Plant-Based Ingredients B2B Sales are the primary driver. The others are pharmaceutical Excipients and Solutions and specialty Ingredients.

Who are Roquette America's main competitors?

Direct peers on record are Ingredion, ADM (Archer Daniels Midland), Tate & Lyle, Kerry Group, DSM-Firmenich, Glanbia, Corbion and Lonza. Cargill is listed as a broad incumbent. Südzucker is listed as a regional player.

Does Roquette America have an API?

No public API is recorded for Roquette America.

What industry is Roquette America in?

Roquette America's product category is Plant-based ingredients for food and pharmaceutical applications. Its primary akta.pro industry code is AFAHAJAI, Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B), with a secondary code of AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing. Its NAICS code is 31122 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comPotato Protein Market Grows as Plant-Based Food Manufacturers Battle Taste, Texture and Protein Quality Challenges with Functional Protein Solutions Forecast 2026-2032QYResearch published a market report forecasting the global potato protein market to grow from US$127 million in 2025 to US$171 million by 2032, driven by demand for plant-based ingredients and animal nutrition. The report highlights key industry players such as Avebe, Tereos, and Roquette, noting that growth is supported by functional properties like emulsification and foaming in food systems. Challenges include raw material seasonality and competition from other plant proteins, while opportunities exist in textured protein innovations and aquafeed applications.BusinessLineSiddharth Rastogi is new MD of Roquette IndiaRoquette, a French company specializing in plant-based ingredients and pharmaceutical excipients, appointed Siddharth Rastogi as Managing Director of Roquette India Pvt Ltd, effective July 1. Rastogi aims to represent the company externally and accelerate growth in India while overseeing the company's operations and strategic initiatives.TalkMarketsPea Starch Concentrate Market to Reach USD 342.6 Million by 2032, Growing at 7.3% CAGRA market research report projects the global pea starch concentrate market will grow from USD 182.4 million in 2024 to USD 342.6 million by 2032, representing a 7.3% CAGR, driven by rising demand for plant-based and clean-label ingredients across food, pharmaceutical, and industrial applications. The report identifies Asia-Pacific as the leading region in supply chain depth and production capacity, while noting Europe and North America as key growth markets driven by consumer preference for allergen-free and sustainable ingredients. Key market players including Roquette, Ingredion, and Cosucra are expanding capacity to capture growth in the plant-based food sector, which is experiencing approximately 13% annual demand growth.TalkMarketsPharmaceutical Pregelatinized Starch Market to Reach USD 2.70 Billion by 2034, Driven by Expanding Pharmaceutical Manufacturing and Generic Drug ProductionThe global pharmaceutical pregelatinized starch market, valued at USD 1.86 billion in 2025, is projected to grow at a CAGR of 4.2% to reach USD 2.70 billion by 2034, driven by expanding pharmaceutical manufacturing, rising generic drug production, and increasing demand for solid oral dosage forms. The market's growth is underpinned by the versatility of pregelatinized starch as a multifunctional excipient serving as binder, disintegrant, and filler, alongside favorable regulatory support from agencies like the FDA and EMA. Key market players including Roquette, Cargill, Colorcon, DFE Pharma, and Beneo are positioned to benefit from growth in emerging economies such as India and China, which account for over 40% of global generic drug production.GlobeNewswireProtein Ingredients Market to Reach USD 121.53 Billion by 2031, Driven by Rising Demand for Functional and High-Protein FoodsAccording to MarketsandMarkets, the global protein ingredients market is projected to grow from USD 78.02 billion in 2025 to USD 121.53 billion by 2031, registering a compound annual growth rate (CAGR) of 7.9% during the forecast period. Europe accounted for the largest regional share at 33.3% in 2025, driven by high demand for meat and meat alternative products, while South America is identified as the fastest-growing region due to rising consumer health awareness and expanding sports nutrition demand. Key recent developments include ADM's launch of eight new plant-based protein ingredients across North America and Europe, Roquette's introduction of a neutral-taste pea protein isolate, and Cargill's expanded partnership with food tech company ENOUGH to develop sustainable mycoprotein-based alternatives.Precedence ResearchUS Pharmaceutical Excipients Market Size to Hit USD 5.58 Billion by 2035The US pharmaceutical excipients market is projected to grow from USD 3.08 billion in 2025 to USD 5.58 billion by 2035, expanding at a compound annual growth rate of 6.12%. This expansion is primarily driven by increasing demand for biologics, specialty drugs, and advanced formulations requiring high-performance ingredients, alongside the integration of artificial intelligence in drug development. Key industry players such as DFE Pharma, MEGGLE Pharma, Roquette, and Evonik are actively investing in capacity expansion and technological innovation to meet these rising requirements.FortunebusinessinsightsPea Processed Ingredients Market Size, ShareThe global pea processed ingredients market was valued at USD 7.66 billion in 2025 and is projected to reach USD 18.21 billion by 2034, growing at a CAGR of 10.12%, driven by rising demand for plant-based, allergen-free, and high-protein foods. Asia Pacific dominated the market with a 47.78% share in 2025, valued at USD 3.66 billion, while North America and Europe held shares of USD 1.41 billion and USD 1.86 billion respectively. Key players including Emsland Group, Kerry Group, DuPont, Roquette Frères, and Ingredion Inc. are driving market growth through product launches, with recent developments including Roquette's AMYSTA™ L 123 launch in October 2025 and Louis Dreyfus Company's USD 500 million pea protein isolate plant opening in Canada in February 2024.GlobeNewswireFunctional Food Ingredients Market Report (2026 Edition) - Plant-Based and Clean-Label Trends Transform the Market LandscapeResearchAndMarkets.com has released the 'Functional Food Ingredients Market (2026 Edition)' report, highlighting steady global market expansion driven by consumer demand for health-enhancing products, plant-based ingredients, and clean-label formulations. The market is shaped by rising lifestyle-related diseases, technological advancements in food processing, and stringent regulatory requirements on labeling and health claims. North America and Europe currently dominate the market, while the Asia-Pacific region is emerging as a high-growth area, with key players including Cargill, Tate & Lyle, Roquette Freres, and DSM competing through innovation and strategic partnerships.FortunebusinessinsightsProtein Ingredients Market Size, ShareThe global protein ingredients market was valued at USD 67.81 billion in 2025 and is projected to reach USD 124.37 billion by 2034, growing at a CAGR of 7.04%, driven by rising demand for high-protein diets, functional nutrition, and sustainable food systems. North America led the market with a 36.67% share in 2025 (USD 24.87 billion), while Asia Pacific is projected to grow at the fastest CAGR of 8.13% during 2026–2034. Key industry developments include Bunge's acquisition of IFF's soy protein concentrate and lecithin businesses in March 2026, alongside multiple product launches from Roquette, Tetra Pak, and Healthier Comforts using alternative protein technologies.PR NewswireFunctional Flour Market to Reach US$ 166.0 Billion by 2032 Expands Amid Rising Demand for Nutrient-Rich and Clean-Label Foods - Persistence Market ResearchThe global functional flour market is projected to grow from US$83.8 billion in 2025 to US$166.0 billion by 2032, with a compound annual growth rate of 10.3%, driven by rising consumer demand for nutrient-rich, clean-label, and health-oriented food ingredients. Specialty flour currently dominates the market with approximately 44% revenue share, while North America leads regionally at around 30% market share, with Asia Pacific expected to record the highest growth rate through 2032. In June 2025, Roquette expanded its NUTRALYS plant-protein portfolio with two new textured protein ingredients, marking the company's entry into the textured wheat protein segment and highlighting increased focus on plant-based protein innovation within the food ingredient sector.